Foley & Lardner LLP Partner Kyle Faget explains the underlying intent and purpose of the federal Anti-Kickback Statute in a four-part video series for LexisNexis Practical Guidance. In the videos, she discusses the protection of federal health care programs, the scope and elements of the law, statutory exceptions, and other laws implicated. Excerpts from the videos are below.
- Federal Anti-Kickback Statute: Protecting Federal Health Care Programs
- Federal Anti-Kickback Statute: Scope and Elements of the Law
- Federal Anti-Kickback Statute: Statutory Exceptions
- Federal Anti-Kickback Statute: Other Laws Implicated
Faget is co-chair of Foley’s Health Care and Life Sciences Practice Groups.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”